The landscape of cancer treatment is continuously evolving with breakthroughs that aim to increase the efficacy of current methods while minimizing side effects. Among the most promising developments is the integration of nanomedicine with cytokine-induced killer (CIK) cell therapy. This innovative approach leverages the precise targeting capabilities of nanotechnology and the powerful antitumor response elicited by CIK cells, offering a formidable strategy against cancer.
